null Option on Iradimed
| IRMD Stock | USD 56.69 0.76 1.32% |
Iradimed's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.56 with a put-to-call open interest ratio of 2.35 over 21 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on October 17th 2025.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Iradimed's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Iradimed's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Iradimed's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Iradimed
Analyzing Iradimed's in-the-money options over time can help investors to take a profitable long position in Iradimed regardless of its overall volatility. This is especially true when Iradimed's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Iradimed's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Iradimed's stock while costing only a fraction of its price.
Iradimed's stock options are financial instruments that give investors the right to buy or sell shares of Iradimed common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Iradimed stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Iradimed's stock price goes up or down, the stock options follow.
At present, Iradimed's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.04, whereas Common Stock Total Equity is forecasted to decline to 1,175. Iradimed In The Money Call Balance
When Iradimed's strike price is surpassing the current stock price, the option contract against Iradimed Co stock is said to be in the money. When it comes to buying Iradimed's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Iradimed Co are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Iradimed Current Options Market Mood
Iradimed's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Iradimed Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Iradimed's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Iradimed's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Iradimed contract
Base on the Rule 16, the options market is currently suggesting that Iradimed Co will have an average daily up or down price movement of about 0.035% per day over the life of the 2025-10-17 option contract. With Iradimed trading at USD 56.69, that is roughly USD 0.0198. If you think that the market is fully incorporating Iradimed's daily price movement you should consider buying Iradimed Co options at the current volatility level of 0.56%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Iradimed options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Iradimed calls. Remember, the seller must deliver Iradimed Co stock to the call owner when a call is exercised.
Iradimed Option Chain
When Iradimed's strike price is surpassing the current stock price, the option contract against Iradimed Co stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Iradimed's option chain is a display of a range of information that helps investors for ways to trade options on Iradimed. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Iradimed. It also shows strike prices and maturity days for a Iradimed against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | IRMD251017C00090000 | 0 | 90.0 | 0.0 - 4.9 | 4.9 | |
Call | IRMD251017C00085000 | 0 | 85.0 | 0.0 - 4.9 | 4.9 | |
Call | IRMD251017C00080000 | 2 | 80.0 | 0.0 - 4.9 | 4.9 | Out |
Call | IRMD251017C00075000 | 1 | 75.0 | 0.0 - 4.9 | 4.9 | Out |
Call | IRMD251017C00070000 | 3 | 70.0 | 0.0 - 4.9 | 4.9 | Out |
Call | IRMD251017C00065000 | 11 | 65.0 | 0.0 - 4.6 | 2.58 | Out |
Call | IRMD251017C00060000 | 0 | 60.0 | 0.3 - 5.0 | 0.3 | |
Call | IRMD251017C00055000 | 6 | 55.0 | 2.0 - 6.7 | 2.0 | In |
Call | IRMD251017C00050000 | 0 | 50.0 | 5.5 - 10.0 | 5.5 | In |
Call | IRMD251017C00045000 | 0 | 45.0 | 10.0 - 14.5 | 10.0 | In |
Put | IRMD251017P00090000 | 0 | 90.0 | 31.0 - 35.5 | 31.0 | In |
Put | IRMD251017P00085000 | 0 | 85.0 | 26.0 - 30.5 | 26.0 | In |
Put | IRMD251017P00080000 | 0 | 80.0 | 21.0 - 25.7 | 21.0 | In |
Put | IRMD251017P00075000 | 0 | 75.0 | 16.0 - 20.5 | 16.0 | In |
Put | IRMD251017P00070000 | 0 | 70.0 | 11.0 - 15.5 | 12.5 | In |
Put | IRMD251017P00065000 | 0 | 65.0 | 6.5 - 11.0 | 6.5 | In |
Put | IRMD251017P00060000 | 50 | 60.0 | 2.5 - 6.8 | 3.6 | In |
Put | IRMD251017P00055000 | 1 | 55.0 | 0.0 - 4.9 | 4.9 | Out |
Put | IRMD251017P00050000 | 1 | 50.0 | 0.0 - 4.8 | 4.8 | Out |
Put | IRMD251017P00045000 | 1 | 45.0 | 0.0 - 4.9 | 1.35 | Out |
Put | IRMD251017P00040000 | 1 | 40.0 | 0.0 - 4.9 | 4.9 | Out |
Iradimed Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Iradimed Market Cap Over Time
Market Cap |
| Timeline |
Iradimed Total Stockholder Equity
Total Stockholder Equity |
|
Iradimed Corporate Management
| Randy Waddell | Vice Marketing | Profile | |
| Jeff Chiprin | Chief Officer | Profile | |
| Lynn Neuhardt | Vice Development | Profile | |
| Chris Williamson | Executive Technology | Profile | |
| Matt Garner | Controller | Profile | |
| Steve Kachelmeyer | Vice Assurance | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.152 | Dividend Share 0.64 | Earnings Share 1.55 | Revenue Per Share | Quarterly Revenue Growth 0.109 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.